AVTX icon

Avalo Therapeutics

18 hedge funds and large institutions have $1.9M invested in Avalo Therapeutics in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$1.01M
2 +$221K
3 +$218K
4
UBS Group
UBS Group
Switzerland
+$168K
5
ACM
ADAR1 Capital Management
Texas
+$131K

Top Sellers

1 -$299K
2 -$45.5K
3 -$4K
4
TRCT
Tower Research Capital (TRC)
New York
-$2.74K
5
Morgan Stanley
Morgan Stanley
New York
-$1.06K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.01M
2
$221K
3
$218K
4
$168K
5
$131K
6
$54.6K
7
$46.2K
8
$35.7K
9
$7K
10
$2K
11
$848
12
$175
13
$87
14
$44
15
$44
16
$43
17
$22
18
$22
19
20